ASX Announcements
December 2020
The green whistle blows for Gordon Naylor’s next move
Former CSL CFO and Seqirus boss Gordon Naylor says all employees need to understand the financial state of a business.
- Yolanda Redrup
Medical Developments seeks $30m in fresh capital
Gordon Naylor, the incoming chairman of the biotech, says there are parallels with ASX giant CSL, where he worked for three decades.
- Carrie LaFrenz
Bell Potter lines up investors for Medical Developments
Emergency pain relief products maker Medical Developments is after $30 million fresh capital via Bell Potter.
- Sarah Thompson, Anthony Macdonald and Tim Boyd
August 2020
Medical Developments buys back European 'green whistle' rights
The ASX minnow's current distribution partner's parent, Purdue Group, is dealing with numerous legal cases relating to the opioid epidemic in the United States.
- Carrie LaFrenz
November 2019
Medical Developments surges on China approval
The company's submission in China is to have Penthrox approved for two separate indications: trauma pain and procedural pain.
- Updated
- Carrie LaFrenz
August 2018
Bell Potter launches Medical Developments placement at skinny discount
Emergency pain relief and respiratory products company Medical Developments International is in front of fund managers seeking an equity injection to fund growth.
- Updated
- Sarah Thompson and Anthony Macdonald
April 2017
Medical Developments pens deals with Walmart and Kmart
Medical Developments has penned deals with US giants Walmart and Kmart to sell several of its respiratory device products.
- Updated
- Carrie LaFrenz
June 2016
Election 2016: CSIRO Manufacturing wrote Turnbull's script
CSIRO Manufacturing's partnership with Boron Molecular is the kind of industry-research collaboration the PM wants to nurture.
- Updated
- Ben Potter
August 2014
What microcap fund managers like
Despite microcap managers being wary of disclosing their key investments, we highlight the stocks liked by five specialist funds.
- Updated
- Tony Featherstone
January 2013
Westpac, NAB hybrid issues next off the rank
Bankers are bracing for another frantic February in the hybrid market as the big banks eye retail targeted capital tier one raisings.
- Sarah Thompson and Anthony Macdonald
Pharmas in favour: Medical Developments eyed
With resources on the nose, investor attention turns to pharmaceutical companies that earn foreign currency and are less affected by the Australian dollar.
- Sarah Thompson and Anthony Macdonald